Randomisation options for all 109 randomised patients
| Options | Patients, n (%) |
|---|---|
| ASC = active symptom control; MVP = mitomycin, vinblastine and cisplatin; N = vinorelbine. | |
| ASC = ASC only; MVP = ASC+MVP; N = ASC+N. | |
| ASC versus MVP versus N | 35 (32) |
| ASC versus MVP | 2 (2) |
| ASC versus N | 15 (14) |
| MVP versus N | 57 (52) |
| All those including ASC only | 52 (48) |